Skip to main content

ARTIVION, INC.

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

AORT$20.47-0.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows

Nine Months EndedSeptember 30,
20252024
Net cash flows from operating activities:
Net income$7,342$3,124
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization16,70117,910
Non-cash compensation20,30211,499
Non-cash lease expense3,8245,860
Write-down of inventories and deferred preservation costs3,7792,911
Deferred income taxes(1,484)(4,187)
Change in fair value of contingent consideration2,390(12,170)
Losses on inducement/extinguishment of debt2,6643,669
Gain from sale of non-financial assets(3,500)—
Other(7,315)1,623
Changes in operating assets and liabilities:
Receivables(924)(3,356)
Inventories and deferred preservation costs(11,563)(4,791)
Prepaid expenses and other assets(4,703)(4,758)
Accounts payable, accrued expenses, and other liabilities(7,193)(5,237)
Net cash flows provided by operating activities20,32012,097
Net cash flows from investing activities:
Capital expenditures(11,534)(9,763)
Payments for Endospan agreements—(7,000)
Net cash flows used in investing activities(11,534)(16,763)
Net cash flows from financing activities:
Proceeds from issuance of long-term debt—190,000
Proceeds from revolving credit facility—30,000
Repayment of debt(207)(211,765)
Proceeds from exercise of stock options and issuance of common stock9,6135,285
Payment of debt issuance costs(1,750)(10,044)
Proceeds from financing insurance premiums3,117—
Principal payments on short-term notes payable(1,395)(1,027)
Other(526)(420)
Net cash flows provided by financing activities8,8522,029
Effect of exchange rate changes on cash and cash equivalents2,325(130)
Increase (decrease) in cash and cash equivalents19,963(2,767)
Cash and cash equivalents beginning of period53,46358,940
Cash and cash equivalents end of period$73,426$56,173

Condensed Consolidated Statements of Stockholders’ Equity

CommonStock · AdditionalPaid-InCapital · RetainedDeficit · Accumulated OtherComprehensive Loss · TreasuryStock · TotalStockholders'Equity
Shares · Amount · Shares · Amount
Balance at June 30, 202548,592$486$497,318$(60,426)$(2,828)(1,487)$(14,648)$419,902
Net income———6,502———6,502
Other comprehensive income, net of tax————541——541
Settlement of convertible senior notes20—460————460
Equity compensation16—6,135————6,135
Exercise of options18113,869————3,870
Employee stock purchase plan5311,283————1,284
Balance at September 30, 202548,862$488$509,065$(53,924)$(2,287)(1,487)$(14,648)$438,694
CommonStock · AdditionalPaid-InCapital · Retained Deficit · Accumulated OtherComprehensive Loss · TreasuryStock · TotalStockholders’Equity
Shares · Amount · Shares · Amount
Balance at December 31, 202443,432$434$376,607$(61,266)$(24,927)(1,487)$(14,648)$276,200
Net income———7,342———7,342
Other comprehensive income, net of tax————22,640——22,640
Settlement of convertible senior notes4,35444102,553————102,597
Equity compensation616620,296————20,302
Exercise of options36337,365————7,368
Employee stock purchase plan9712,244————2,245
Balance at September 30, 202548,862$488$509,065$(53,924)$(2,287)(1,487)$(14,648)$438,694

Condensed Consolidated Statements of Stockholders’ Equity (continued)

CommonStock · AdditionalPaid-InCapital · RetainedDeficit · Accumulated OtherComprehensive Loss · TreasuryStock · TotalStockholders'Equity
Shares · Amount · Shares · Amount
Balance at June 30, 202443,279$433$367,627$(42,495)$(15,861)(1,487)$(14,648)$295,056
Net loss———(2,288)———(2,288)
Other comprehensive income, net of tax————6,333——6,333
Equity compensation11—3,940————3,940
Exercise of options35—676————676
Employee stock purchase plan6711,021————1,022
Balance at September 30, 202443,392$434$373,264$(44,783)$(9,528)(1,487)$(14,648)$304,739
CommonStock · AdditionalPaid-InCapital · RetainedDeficit · AccumulatedOtherComprehensiveLoss · TreasuryStock · TotalStockholders’Equity
Shares · Amount · Shares · Amount
Balance at December 31, 202342,569$426$355,919$(47,907)$(12,010)(1,487)$(14,648)$281,780
Net income———3,124———3,124
Other comprehensive income, net of tax————2,482——2,482
Equity compensation499512,063————12,068
Exercise of options20623,522————3,524
Employee stock purchase plan11811,760————1,761
Balance at September 30, 202443,392$434$373,264$(44,783)$(9,528)(1,487)$(14,648)$304,739
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.